PRDX3 and nasopharyngeal carcinoma: The combined detection of VCA-IgA and autoantibodies against PRDX2 and PRDX3 had a better diagnostic sensitivity than VCA-IgA tested alone (Table 3; Fig. 4) and a robust specificity, indicating that this test might make a contribution to the diagnosis and screening of NPC patients.